Localisation of Cannabinoid and Cannabinoid-Related Receptors in the Horse Ileum.

The research paper illustrates the exploration and mapping of the presence and position of cannabinoid and cannabinoid-related receptors in the intestines (ileum) of healthy horses, an area previously unexplored. This study provides a groundwork for potential advances in equine medicine, particularly in the treatment of common digestive disorders, utilizing non-psychotic cannabis-derived molecules.

Objective of the Study

• The goal was to determine the cellular distribution of canonical and putative cannabinoid receptors in the ileum of healthy horses through immunohistochemical processing. This research was motivated by literature suggesting potential benefits of cannabinoid receptor activation on gastrointestinal inflammation and intestinal discomfort, common issues in equine medicine.

Methodology

• Tissue samples for this study were collected from the distal ileum of six horses at a slaughterhouse. These samples were then prepared into cryosections.
• The distribution of canonical cannabinoid receptors 1 and 2 (CB1R and CB2R), and three presumptive cannabinoid-related receptors (PPARα, Transient receptor potential ankyrin 1, and 5-HT1aR) was investigated in the cryosections for their immunoreactivity.

Results of the Study

• The cannabinoid and cannabinoid-related receptors were found scattered broadly in the ileum of the horses. The approach identified immunoreactivity in various cells types, including epithelial cells, lamina propria inflammatory cells, enteric neurons, enteric glial cells, and smooth muscle cells.
• The epithelial cells showed immunoreactivity for CB1R, CB2R, and 5-HT1aR, while lamina propria inflammatory cells showed immunoreactivity for CB2R and 5-HT1aR.
• CB1R, Transient receptor potential ankyrin 1, and PPARα were present in enteric neurons, while CB1R and PPARα were found in enteric glial cells. The smooth muscle cells exhibited immunoreactivity for PPARα.

Implications of the Study

• The study provides a foundation for further investigations into the distribution of these receptors during gastrointestinal inflammatory diseases in horses.
• Ultimately, this research can assist future studies assessing the potential use of non-psychotic cannabis-derived molecules in the management of intestinal diseases in horses, providing a novel approach to treat common equine digestive disorders such as colic.